Search for dissertations about: "brain metastases"
Showing result 1 - 5 of 16 swedish dissertations containing the words brain metastases.
-
1. Gadodiamide injection for Enhancement of MRI in the CNS. Applications, dose, field and time dependence
Abstract : Aims of the study The aims of this study using Gadodiamide injection were to investigate: · Whether Gadodiamide injection was comparable to Gd-DTPA for the enhancement of CNS lesions. · The contrast effect at different field strengths. · The effective time-window for the enhancement of blood-brain barrier damage. READ MORE
-
2. Breast cancer : brain metastases and treatment aspects
Abstract : Background: In Sweden breast cancer is the most common malignant cancer disease among women, with 8000 new individual cases each year. The prognosis is generally very good, but nevertheless many patients still die of breast cancer every year. READ MORE
-
3. Hypofractionated conformal stereotactic radiotherapy in the treatment of AVMs and cerebral metastases
Abstract : Hypofractionated conformal stereotactic radiotherapy (HCSRT) has been used for the treatment of AVMs at the Umeå University Hospital since 1986. From this year and onwards an increasing number of patients with single or oligo brain metastases have also been treated using this technique. READ MORE
-
4. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas
Abstract : Contrast-enhanced magnetic resonance imaging (MRI) of the liver and pancreas is frequently performed to improve the sensitivity and specificity of lesion detection in these organs. The concept of using tissue-specific contrast media is to selectively enhance the normal parenchyma, but not lesions, so that the contrast between tumorous and normal tissue is increased, and lesion detectability improved. READ MORE
-
5. HER2-receptor quantification in breast cancer patients by imaging with ABY-025 Affibody and PET
Abstract : Breast cancer is the most common malignancy in women worldwide. Human epidermal growth factor receptor type 2 (HER2) is overexpressed in up to 20% of breast cancer cases and is considered an important prognostic factor and a therapeutic target. READ MORE